Synaffix BV is a clinical-stage biotechnology company exclusively focused on the advancement of our best-in-class antibody-drug conjugate (ADC) technology platform.
Our core values include transparency, scientific excellence and embracing the collective genius across our team.
As a leading innovator in the field of ADC technology, our vision is to be the preferred proprietary technology source for biotech and pharma companies that are looking to enhance the competitive profile of their targeted cancer therapeutics pipeline. These continued efforts are aimed at improving the health of patients globally and to realize our ambition – Connect to Cure.
If you are interested in becoming part of our exciting and dynamic team, please get in touch with us at firstname.lastname@example.org.